Repligen RGEN
NASDAQ RGEN
$178.16 +5.25 (+3.04%)
As of: Sep 17, 2026 · 3:59 PM EDT

Repligen (RGEN) Gross Margin Growth (1y) (2011 - 2026)

Analysis

Repligen (RGEN) Gross Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -59.00
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -171.00
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 439.00
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 81.00
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 263.00
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 309.00
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 13.00
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 291.00
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 214.00
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 473.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 291.00
Mar 31, 2026 173.00
Dec 31, 2025 2,928.00
Sep 30, 2025 320.00
Jun 30, 2025 -33.00
Mar 31, 2025 388.00
Dec 31, 2024 -2,392.00
Sep 30, 2024 2,414.00
Jun 30, 2024 115.00
Mar 31, 2024 -38.00
Dec 31, 2023 -433.00
Sep 30, 2023 -3,101.00
Jun 30, 2023 -828.00
Mar 31, 2023 -959.00
Dec 31, 2022 -458.00
Sep 30, 2022 -74.00
Jun 30, 2022 -350.00
Mar 31, 2022 193.00
Dec 31, 2021 34.00
Sep 30, 2021 -23.00